CClinicalTrials.gg
Active, not recruitingNCT06819813VIBEUpdated Jul 8, 2026

Project VIBE: Virtual Intervention for Binge Eating in Adolescents

An interventional study of Feasibility/Efficacy Testing in Obesity, Binge-Eating Disorder and Binge Eating, sponsored by University of Pittsburgh. Active, not recruiting at 2 sites in United States. Open to participants aged 13 Years to 19 Years. Per ClinicalTrials.gov, last updated 2026-07-08.

Sponsored by University of Pittsburgh · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
13 Years to 19 Years
Sex
All
01

Study summary

The aim of this project is to pilot test a novel mobile app intervention for adolescents with dysregulated eating behaviors and elevated weight status. This intervention will incorporate evidence-informed strategies targeting self-regulation into cognitive-behavioral treatment for maladaptive eating. Adolescents will use the app for 16 weeks and provide feedback on its usability and effectiveness in managing dysregulated eating.

Read the detailed description

This trial is part of a multi-phase project to create and test a mobile app intervention aimed at helping teenagers regulate their eating behaviors. Participation in this trial involves the following:

  1. Adolescents and their parent are asked to attend a virtual assessment visit, where they will provide consent and complete questionnaires on eating-related thoughts and behaviors, mood, and experience with technology. The adolescent will also be asked to complete a semi-structured interview and provide height/weight measurements.
  2. Eligible adolescents are then asked to complete a test-run week to make sure the trial is a good fit for them. They will be mailed a FitBit to wear continuously during the test-run week and a Smartscale to record their weight. They will also complete three 24-hour food recalls with a member of the research team during this week. Depending on engagement, the adolescent may or may not be invited to participate in the 16-week trial.
  3. Adolescents eligible for the trial will use the VIBE app (Virtual Intervention for Binge Eating) and receive coaching for 16 weeks. Participants will also be asked to download an app that will help them with skill building and problem solving through short tasks/games, to be used while they are participating in the 16-week intervention.
  4. Throughout the trial, adolescents will be invited to complete 3 additional assessment visits: "mid-point" or 8 weeks after starting the intervention, "post-intervention" at the end of the 16-week intervention, and "follow-up" 4 months after completing the intervention. These study assessments will include an interview, a weight measurement using the Smartscale, Fitbit usage for one week, up to 3 dietary recall phone calls, computerized tasks to assess how they think and solve problems, and online surveys. Each assessment will take about 90 - 120 minutes to complete.
02

Conditions studied

  • Obesity
  • Binge-Eating Disorder
  • Binge Eating

Keywords

  • Mobile Intervention
  • Adolescent
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 50 is below the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

University of Pittsburgh is the lead sponsor of 1,385 studies on the registry; 167 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 4 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • BMI≥75th percentile for their age and sex
  • Report recent loss of control eating and/or overeating (≥3 episodes of either type of eating behavior in the past 3 months)
  • Have an email address, Smartphone, and regular access to the internet
  • Be willing and able to measure their height and weight prior to study enrollment

Exclusion criteria

Exclusion Criteria:

  • Report more than 2 instances of compensatory behavior (e.g. diuretics, laxatives, vomiting, driven exercise) in the past 3 months
  • Not fluent in English at a third-grade reading level or higher
  • Currently taking medications known to affect weight or appetite or concurrently involved in treatment for eating or weight disorders
  • Meet criteria for a medical or psychiatric condition (e.g., diabetes, bulimia nervosa) known to significantly affect eating or weight, aside from binge eating disorder
  • Developmental or cognitive delay precluding participation in the intervention
  • Currently pregnant or lactating
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Feasibility/Efficacy Testing Participants

    All participants will all be assigned to the experimental group in this single-arm open trial.

    Behavioral: Feasibility/Efficacy Testing

Interventions

  • BehavioralFeasibility/Efficacy Testing

    This digital intervention will include elements of adapted cognitive-behavioral treatment for adolescent binge eating and weight control, with a focus on self-regulation and skills use.

06

What researchers measure

Primary outcomes

  1. Usability of intervention

    Perceptions that the intervention is or would be useful, useable, and satisfactory will be measured by the System Usability Scale.

    Time frame: Week 16

  2. Acceptability of intervention

    Perceptions that the intervention is or would be useful, useable, and satisfactory will be measured by the Usefulness, Satisfaction, and Ease of use questionnaire (USE).

    Time frame: Week 16

  3. Body mass index percentile

    Adolescents will have their height and weight measured to calculate body mass index percentile using nationally representative growth charts and accompanying procedures. These data will be collected at each of the 4 major time points (pre-intervention assessment, mid-intervention assessment, post-intervention assessment, and 4-month follow up assessment).

    Time frame: Through study completion (up to 9 months)

  4. Dysregulated eating

    Dysregulated eating (overeating and loss of control eating episodes) will be measured using the Eating Disorder Examination (EDE; interview and questionnaire). The EDE features 4 subscales that are rated on a 7-point forced-choice format (0-6), with higher scores reflecting greater severity or frequency. These measures will be completed at each of the 4 major time points (pre-intervention assessment, mid-intervention assessment, post-intervention assessment, and 4-month follow up assessment).

    Time frame: Through study completion (up to 9 months)

Other outcomes

  1. Comorbid diagnoses

    Comorbid psychiatric diagnoses will be reported by the adolescent's caregiver using the Child and Adolescent Symptom Inventory (CASI). Medical comorbid diagnoses will be reported by both the adolescent and their caregiver.

    Time frame: Pre-intervention assessment

  2. Intervention targets (activity patterns)

    Activity patterns (intervention target) will be measured using FitBit data during the intervention. Adolescents will track their activity using the FitBit over a 1-week period at each of the 4 major time points (pre-intervention assessment, mid-intervention assessment, post-intervention assessment, and 4-month follow up assessment).

    Time frame: Through study completion (up to 9 months)

  3. Intervention targets (dietary patterns)

    Dietary patterns (intervention target) will be measured using phone-based 24-hour dietary recalls. Adolescents will complete 3 food recalls over a 1-week period at each of the 4 major time points (pre-intervention assessment, mid-intervention assessment, post-intervention assessment, and 4-month follow up assessment)

    Time frame: Through study completion (up to 9 months)

  4. Putative treatment mechanisms (general)

    General self-regulation (putative mechanism) will be measured using the Self-Regulation Questionnaire. Items on the Self-Regulation Questionnaire are scored from 1 (strongly disagree) to 5 (strongly agree), with higher scores indicated higher self-regulation abilities. The questionnaire will be completed at each of the 4 major time points (pre-intervention assessment, mid-intervention assessment, post-intervention assessment, and 4-month follow up assessment).

    Time frame: Through study completion (up to 9 months)

07

Study locations

2 sites
  • Northwestern University
    Chicago, Illinois 60208, United States
  • University of Pittsburgh
    Pittsburgh, Pennsylvania 15213, United States
08

References and documents

Publications

  • Goldschmidt AB, Ortega A, Rooper IR, Obleada KT, Chapa DAN, Silverberg B, Stalvey E, Camino MK, Levine MD, Yu L, Eichen DM, Graham AK. Virtual Intervention for Binge Eating (VIBE): Study protocol for a user-informed mobile intervention for dysregulated eating and weight gain prevention in adolescents. Contemp Clin Trials. 2026 Feb;161:108192. doi: 10.1016/j.cct.2025.108192. Epub 2025 Dec 18. PubMed 41421758 ↗

Study documents

  • Informed consent form · Jan 15, 2026

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Research data from participants may be shared with the broader scientific community after publication. We will make data and documentation available only under a data-sharing agreement that provides for a commitment to: (1) use the data for research purposes only; (2) secure the data using appropriate computer technology; (3) destroy or return the data after analyses are completed; and (4) not attempt to identify participants individually. Information shared with outside collaborators will link personal health information to a unique study ID in order to maintain participant anonymity.

Supporting information: Study protocol, Sap, Icf

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06819813
Lead sponsor
University of Pittsburgh
Collaborators
Northwestern University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Responsible party
Andrea Goldschmidt (Associate Professor of Psychiatry, University of Pittsburgh) — Principal investigator
First posted
Feb 11, 2025
Start date
Jul 14, 2025
Primary completion
Oct 15, 2026 (estimated)
Completion
May 30, 2027 (estimated)
Last update
Jul 8, 2026

Study contacts

Andrea B Goldschmidt, Ph.D.
principal investigator · University of Pittsburgh
Andrea K Graham, Ph.D.
principal investigator · Northwestern University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion